Amgen to Help Develop Autoimmune Drugs
Amgen Inc. and EVOQ Therapeutics on Wednesday announced they have entered into a license and collaboration agreement to develop drugs for autoimmune disorders.
Amgen Inc. and EVOQ Therapeutics on Wednesday announced they have entered into a license and collaboration agreement to develop drugs for autoimmune disorders.